Group 1 - The company has business operations exporting and selling to EU member states, although the revenue from the EU region constitutes a relatively small portion of the overall revenue [1] - The primary export markets for the company are South America, the Middle East, and Southeast Asia [1] - Sales to the EU market are mainly conducted through local agents in the EU [1]

Core Viewpoint - Anhui Heli stated that by the third quarter of 2025, the revenue from its EU export business is expected to account for approximately 7% of the company's total revenue [2] Group 1: Company Overview - The company has established several sales and research institutions in Europe, including Heli European Center in France, Heli European Headquarters in Germany, and Heli European R&D Center [2] - Sales in the European region are primarily conducted through a combination of the company's sales institutions and agents [2]

Group 1 - The company has established wholly-owned subsidiaries for direct sales in several EU countries, including Germany, the UK, France, the Netherlands, Portugal, and Switzerland, while adopting a distribution model in other EU nations [2] - The company completed the acquisition of 51% of the Spanish company CreoMedical S.L.U. in February 2025, which enhances its sales channels for medical devices in Western Europe, primarily focusing on direct sales [2] - In the first three quarters of 2025, the company's export revenue from the EU accounted for approximately 26.8% of its total revenue, including the consolidation of CME [2]